Rwanda, Mpox
The European Commission on Friday extended the authorization of the Imvanex mpox vaccine to teenagers aged 12 to 17.
The EU's drug regulator has approved Bavarian Nordic's mpox vaccine for use in adolescents aged 12 to 17 years, the company ...
Lessons learned from the COVID pandemic have left the world in a much better position to tackle the current mpox epidemic ...
With more than 200 mpox-related deaths reported globally, the EMA has approved Imvanex for adolescents aged 12-17 years.
LONDON (Reuters) -Bavarian Nordic said on Thursday its mpox vaccine was approved by the EU's drug regulator for use in ...
Congo's South Kivu province is at the epicenter of the world’s latest mpox outbreak, in what the World Health Organization ...
The World Health Organization announced Friday it has authorized the use of an mpox vaccine, calling it an “important step” ...
The World Health Organization and partners on Friday set up a scheme to help bring mpox vaccines, tests and treatments to the ...
As the World Health Organization (WHO) has declared mpox an emergency, the Clinical Trials Arena team investigates ongoing ...